Development of a Targeted Multi-Disorder High-Throughput Sequencing Assay for the Effective Identification of Disease-Causing Variants-Reference-Cited by-同舟云学术

Development of a Targeted Multi-Disorder High-Throughput Sequencing Assay for the Effective Identification of Disease-Causing Variants

Published:2015-07-27 Issue:7 Volume:10 Page:e0133742
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Delio Maria,Patel Kunjan,Maslov Alex,Marion Robert W.,McDonald Thomas V.,Cadoff Evan M.,Golden Aaron,Greally John M.,Vijg Jan,Morrow Bernice,Montagna Cristina

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. Molecular diagnosis for heterogeneous genetic diseases with targeted high-throughput DNA sequencing applied to retinitis pigmentosa;DA Simpson;J Med Genet,2011

2. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing;KP Kenna;J Med Genet,2013

3. A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases;K Neveling;Hum Mutat,2013

4. Targeted sequence capture and GS-FLX Titanium sequencing of 23 hypertrophic and dilated cardiomyopathy genes: implementation into diagnostics;OR Mook;J Med Genet,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical exome sequencing uncovers an unsuspected diagnosis of Bartter syndrome type 2 in a child with incidentally detected nephrocalcinosis;CEN Case Reports;2022-02-23

2. SNPs Classification and Terminology: dbSNP Reference SNP (rs) Gene and Consequence Annotation;Single Nucleotide Polymorphisms;2022

3. A practical approach to the genomics of kidney disorders;Pediatric Nephrology;2021-03-06

4. A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients;BMC Medicine;2020-08-26

5. Utility of the “omics” in kidney disease: Methods of analysis, sampling considerations, and technical approaches in renal biomarkers;Kidney Biomarkers;2020